RecruitingNCT03711539

Lifetime Endurance Exercise to Prevent Coronary Artery Disease

Lifetime Endurance Exercise to Prevent Coronary Artery Disease. A Comparison With Late-onset Endurance Training and a Sedentary Lifestyle


Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

1,800 participants

Start Date

Oct 18, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

The primary objective of the Master@Heart Trial is to investigate whether lifelong endurance exercise reduces the incidence of non-calcified plaques (both mixed and soft plaques) as compared to late-onset endurance exercise and a non-athletic lifestyle.


Eligibility

Sex: MALEMin Age: 45 YearsMax Age: 70 Years

Inclusion Criteria22

  • Lifelong endurance athletes:
  • Initiation of endurance sports before the age of 30 years
  • Activities at regional, national or international level
  • Sports: triathlon, cycling, distance running (1500 metres and longer) and rowing
  • Aged 45-70 years
  • Involved in competition and high-level training:
  • more than 10 hours per week for cyclists and triathletes
  • more than 6 hours per week for runners and rowers.
  • Late-onset endurance athletes:
  • Initiation of endurance sports after the age of 30 years and at least 6 months ago
  • Activities at regional, national or international level
  • Sports: triathlon, cycling, distance running (1500 metres and longer) and rowing
  • Aged 45-70 years
  • Involved in competition and high-level training:
  • more than 10 hours per week for cyclists and triathletes
  • more than 6 hours per week for runners and rowers.
  • Healthy non-athletes
  • subjects seen in the outpatient clinic for a work-related medical check-up
  • university alumni
  • subjects from multisports organisations
  • history of regular sports practice \<3 hours /week
  • participation in regular sports with a low dynamic component (e.g. billiards, darts or bowling) \>3 hours /week is allowed

Exclusion Criteria4

  • history of smoking (\> 5 pack years)
  • history of diabetes
  • diagnosis of cardiopulmonary disorder prior to inclusion
  • medical treatment for arterial hypertension or hypercholesterolemia

Locations(3)

University Hospital, Antwerpen

Edegem, Belgium

Jessa Hospital

Hasselt, Belgium

UZLeuven

Leuven, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03711539


Related Trials